Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · U.S. Physical Therapy (USPH)

U.S. Physical Therapy Q1 revenue rises 7.9% to $198.3 million; guidance reaffirmed

Mixed Impact 3 of 5 earnings Written later

U.S. Physical Therapy reported first-quarter 2026 net revenue of $198.3 million, up 7.9% from a year earlier, but net income attributable to shareholders fell to $5.0 million and the company posted a loss of $0.12 per share, compared with earnings of $0.80 per share in the prior-year quarter. Management reaffirmed full-year 2026 adjusted EBITDA guidance of $102.0 million to $106.0 million and declared a quarterly dividend of $0.46 per share.

Key points

  • Net revenue was $198.3 million, up 7.9% from $183.8 million in Q1 2025.
  • Net income attributable to USPH shareholders was $5.0 million, versus $9.9 million; the filing cites a $2.0 million loss on the change in fair value of contingent earn-out consideration.
  • Full-year 2026 adjusted EBITDA guidance of $102.0 million to $106.0 million was reaffirmed.
  • Quarterly dividend of $0.46 per share is payable June 12, 2026, to shareholders of record on May 22, 2026.

The filing

CompanyU.S. Physical Therapy (USPH)
Form8-K, current report
Filed with the SECMay 6, 2026, 4:30 PM ET
Accession number0000885978-26-000019

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.